Temsirolimus

torisel
Temsirolimus (codenamed CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S.wikipedia
0 Related Articles
No Results Found!